Chesapeake Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20
Closed -$3.88K 386
2025
Q3
$3.88K Hold
20
﹤0.01% 270
2025
Q2
$10.5K Buy
20
+5
+33% +$397 0.01% 213
2025
Q1
$5.28K Buy
15
+3
+25% +$280 0.01% 263
2024
Q4
$410 Buy
+12
New +$1.24K ﹤0.01% 416

Other funds holding MRK

Chesapeake Asset Management's MRK Position: Q1 2026 in Review

Chesapeake Asset Management reduced its Merck (MRK) stake by 6.9% in Q1 2026, selling an estimated $128K and leaving 15,053 shares worth $1.81M. The position accounts for 1.44% of the portfolio, ranked #14.

Chesapeake Asset Management first reported a position in MRK in Q2 2013 and has held it in 40 quarters since. The position peaked at $5M in Q3 2014. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Chesapeake Asset Management held 15,053 shares of Merck worth $1.81M as of Q1 2026.
  • Chesapeake Asset Management sold 1,113 Merck shares in Q1 2026, an estimated $128K.
  • Merck made up 1.44% of Chesapeake Asset Management's portfolio in Q1 2026, its #14 holding.
  • Chesapeake Asset Management first reported a position in Merck in Q2 2013 and has held it in 40 quarters since.
  • Chesapeake Asset Management's Merck position peaked at $5M in Q3 2014.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.